Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cocaine-Related DisordersCocaine AddictionSubstance-Related Disorders
Interventions
DRUG

Corticotropin-Releasing Hormone

Each subject will receive a single dose of Corticotropin-Releasing Hormone corticorelin on a single occasion, and a volume-matched saline injection on a second occasion. Corticorelin will be administered as an intravenous infusion over a 30- to 60-second interval at a dose of 1 ug/kg body weight. \~15 minutes after Corticorelin/saline injection, \[11C\]-(+)-PHNO will be administered followed by 90 minutes of PET scanning. Primary outcome measure (\[11C\]-(+)-PHNO) as well as Secondary outcome measures (self reported feeling, hormones and physiological measures) will be obtained before saline or Corticorelin/saline injection and for 90-120 minutes following injection.

Trial Locations (1)

M5T 1R8

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT01984177 - Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence | Biotech Hunter | Biotech Hunter